Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Ryanair
RYAAY
$29.2B
| $7.64M | ﹤0.01% |
173,623
-33,515
| -16% | -$1.45M |
|
2352
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.7B
| $7.64M | ﹤0.01% |
80,957
+66,257
| +451% | +$6.33M |
|
2353
PUT
PPG Industries
PPG
$25.3B
| $7.64M | ﹤0.01% |
53,400
-30,000
| -36% | -$4.81M |
|
|
RKTA
2354
DELISTED
Rocket Internet Growth Opportunities Corp.
RKTA
| $7.63M | ﹤0.01% |
781,012
+490,080
| +168% | +$4.76M |
|
2355
VF Corp
VFC
$5.41B
| $7.63M | ﹤0.01% |
113,825
-1,155
| -1% | -$88.6K |
|
2356
Legend Biotech
LEGN
$3.91B
| $7.62M | ﹤0.01% |
150,707
+92,867
| +161% | +$3.86M |
|
2357
Costamare
CMRE
$1.87B
| $7.6M | ﹤0.01% |
490,614
+301,409
| +159% | +$3.89M |
|
|
ZLSWU
2358
DELISTED
Zalatoris II Acquisition Corp Unit
ZLSWU
| $7.59M | ﹤0.01% |
+772,600
| New | +$7.62M |
|
2359
Virtu Financial
VIRT
$6.02B
| $7.59M | ﹤0.01% |
310,806
+234,721
| +308% | +$5.96M |
|
2360
Constellium
CSTM
$3.71B
| $7.59M | ﹤0.01% |
403,978
-249,895
| -38% | -$4.81M |
|
2361
Orthofix Medical
OFIX
$396M
| $7.58M | ﹤0.01% |
198,855
-5,497
| -3% | -$219K |
|
|
TBCH
2362
Turtle Beach Corp
TBCH
$225M
| $7.56M | ﹤0.01% |
271,886
+205,032
| +307% | +$5.98M |
|
2363
CALL
Mercado Libre
MELI
$99.1B
| $7.56M | ﹤0.01% |
4,500
| – | – |
|
|
FICVU
2364
DELISTED
Frontier Investment Corp Units
FICVU
| $7.55M | ﹤0.01% |
+766,630
| New | +$7.6M |
|
|
CTAC
2365
DELISTED
Cerberus Telecom Acquisition Corp.
CTAC
| $7.54M | ﹤0.01% |
965,511
+143,983
| +18% | +$1.43M |
|
|
MCFE
2366
DELISTED
McAfee Corp. Class A Common Stock
MCFE
| $7.53M | ﹤0.01% |
340,503
+315,332
| +1,253% | +$8.15M |
|
|
TBIO
2367
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $7.53M | ﹤0.01% |
37,576
-2,139
| -5% | -$543K |
|
|
CPAAU
2368
DELISTED
Conyers Park III Acquisition Corp. Unit
CPAAU
| $7.53M | ﹤0.01% |
+745,000
| New | +$7.46M |
|
2369
Affiliated Managers Group
AMG
$9.63B
| $7.51M | ﹤0.01% |
49,687
-97,429
| -66% | -$16M |
|
2370
iShares Core US Aggregate Bond ETF
AGG
$138B
| $7.5M | ﹤0.01% |
65,328
-124,689
| -66% | -$14.5M |
|
2371
Guardant Health
GH
$22.2B
| $7.49M | ﹤0.01% |
59,950
-239,359
| -80% | -$28.4M |
|
2372
Hewlett Packard
HPE
$70.6B
| $7.48M | ﹤0.01% |
525,058
+408,840
| +352% | +$5.9M |
|
2373
Cooper Companies
COO
$13.8B
| $7.48M | ﹤0.01% |
72,392
+54,364
| +302% | +$5.8M |
|
2374
PUT
Zebra Technologies
ZBRA
$17.2B
| $7.47M | ﹤0.01% |
14,500
+7,100
| +96% | +$3.96M |
|
2375
Boot Barn
BOOT
$4.72B
| $7.47M | ﹤0.01% |
84,010
-6,603
| -7% | -$569K |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.